Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Methylphenidate vs Ritalin in Children with ADHD
NCT00269789Phase 3Completed
- Sponsor
- ALZA Corporation
- Start
- Mar 1998
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by ALZA Corporation. Primary endpoint: IOWA Conners Inattention/Overactivity subscale ratings by Community School Teacher at Day 20. Started Mar 1998; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00269789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269789.